Trial Profile
Safety of Acamprosate for Alcohol Dependence in the Elderly: An Open-Label Study
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 02 Aug 2023
Price :
$35
*
At a glance
- Drugs Acamprosate (Primary)
- Indications Alcoholism
- Focus Adverse reactions
- Acronyms SAFADIE
- 02 Aug 2023 Status changed from recruiting to withdrawn prior to enrolment.
- 28 Feb 2017 New trial record